Page last updated: 2024-10-25

deferoxamine and Hepatitis, Chronic

deferoxamine has been researched along with Hepatitis, Chronic in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Virgiliis, S1
Argiolu, F1
Rais, M1
Cossu, P1
Toccafondi, C1
Sanna, G1
Cornacchia, G1
Nucaro, A1
Ferreli, A1
Cao, A1
Angelucci, E1
Baronciani, D1
Lucarelli, G1
Giardini, C1
Galimberti, M1
Polchi, P1
Martinelli, F1
Baldassarri, M1
Muretto, P1

Other Studies

2 other studies available for deferoxamine and Hepatitis, Chronic

ArticleYear
Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    Birth defects original article series, 1982, Volume: 18, Issue:7

    Topics: Aspartate Aminotransferases; Child; Child, Preschool; Deferoxamine; Hepatitis B; Hepatitis B Surface

1982
Liver iron overload and liver fibrosis in thalassemia.
    Bone marrow transplantation, 1993, Volume: 12 Suppl 1

    Topics: Adolescent; Adult; Chelation Therapy; Child; Child, Preschool; Combined Modality Therapy; Deferoxami

1993